New Delhi, Dec 23 (IANS) A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet.”The induction of antibodies within 1 month of vaccination, along with the persistence afforded by two dosages, suggests the vaccine ca…
Trending
- Dark Movie Review: Ajay Karthi’s Atmospheric Horror-Thriller Delivers Genuine Chills
- Super Subbu Review: Sundeep Kishan’s Bold Netflix Series Blends Humour, Heart, and a Powerful Message
- Nevermind 2026 Movie Review: Rituparna Sengupta Anchors a Hauntingly Atmospheric Bengali Mystery-Drama
- Rao Bahadur Movie Review: Satyadev Delivers a Career-Defining Performance in This Bold Psychological Drama
- Graamaayana Movie Review: Vinay Rajkumar’s Heartfelt Rural Drama Wins Hearts
- Alpha Movie Review: Alia Bhatt and Sharvari Redefine Action Cinema in YRF’s Boldest Spy Universe Chapter Yet
- Nagabandham: The Secret Treasure Movie Review — A Grand Mythological Adventure Worth Experiencing
- Isakapatnam Review: Aishwarya Rajesh and Samuthirakani Deliver a Gripping Coastal Crime Saga